Together, our analysis and previous research suggests that LY6D expression may indicate a more aggressive pancreatic cancer phenotype and it would therefore be beneficial to explore the precise mechanism of action for LY6D to determine its therapeutic potential. Here, LY6D is linked to pancreatic neoplasm.